Yu-Dong Sun

Dr. Yu-Dong Sun


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
XWXiaolong Wei
Xiaolong Wei
YSYu-Dong Sun
Yu-Dong Sun
THTonglei Han
Tonglei Han
JZJiang Zhu
Jiang Zhu
YXYongfu Xie
Yongfu Xie
ZJZaiping Jing
Zaiping Jing
The aim of this study was to investigate the relationship between Talin-1 and stability of carotid atherosclerosis plaque and also find out the role of miRNA, as an upstream regulator, in regulating the expression level of Talin-1. Human carotid plaques were obtained from 20 symptomatic carotid stenosis patients who underwent carotid endarterectomy (CEA) in our hospital between October 2014 and August 2017. Western blot analysis and immunohistochemistry was carried out to detect the distribution and expression level of Talin-1 in each plaque sample. The content of miRNAs in carotid plaque was decected by quantitative reverse transcription polymerase chain reaction (RT-qPCR), and the relative expression levels were calculated by 2-△△Ct method after the (cycle threshold) Ct value (power amplification knee point) was obtained. Dual-luciferase reporter assays were applied to verify the successful transfections. Finally, we compared all the groups with independent-samples t-test and one-way analysis of variance (ANOVA). Talin-1 was significantly downregulated in human unstable carotid plaque samples compared with stable carotid plaques (P < 0.05), and the distribution of Talin-1 was mainly found in the fibrous cap of carotid plaque. The overexpression of miRNA-330-5p was found in unstable carotid plaque, which significantly induced the inhibition of expression level of Talin-1. Upregulated miR-330-5p may lead to unstable carotid plaques by targeting Talin-1 in symptomatic carotid stenosis patients. This might be a new target for the treatment of atherosclerotic diseases through future studies.

1 January 2022
Verified
Journal Article
Closed access
JMJiqing Ma
Jiqing Ma
JLJianhua Luo
Jianhua Luo
YSYu-Dong Sun
Yu-Dong Sun
ZZZhiqing Zhao
Zhiqing Zhao

4 March 2026 in Nanoscale
Verified
Journal Article
Closed access
PDF file
SHShutong He
Shutong He
LLLei Li
Lei Li
YLYaoda Liu
Yaoda Liu
JSJie Su
Jie Su
YSYu-Dong Sun
Yu-Dong Sun
Zhengfei DaiZhengfei Dai
Zhengfei Dai
A lateral Ni 2 P/NiO porous hierarchitecture has been synthesized through a facile in situ topological transformation from black phosphorene, demonstrating highly sensitive and selective sensing properties for trace H 2 S detection.

24 September 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
XMXiaochen Ma
Xiaochen Ma
ZWZhishi Wu
Zhishi Wu
GZGuanglang Zhu
Guanglang Zhu
MGMingjin Guo
Mingjin Guo
YLYongxin Li
Yongxin Li
\M\R\Nxiaochen Ma
\R\Nxiaochen Ma
Purpose: To compare the long-term efficacy of the parallel stent graft (PSG), fenestrated stent graft (FSG), and branched stent graft (BSG) techniques to treat thoracoabdominal aortic pathologies.Materials and methods: In total, 291 patients with thoracic aortic aneurysm (TAA) and dissection (TAD) involving visceral arteries who underwent PSG (n = 85; 15 TAA and 70 TAD), FSG (n = 107; 47 TAD and 60 TAA), or BSG (n = 99; 37 TAD and 62 TAA) were included from multiple centers from January 2015 to December 2022, and a total of 1,108 visceral aortic branches were reconstructed.Results: The average reconstruction time of each visceral aortic branch for FSG, BSG, and PSG is 27.5 ± 12.1, 23.2 ± 11.9, and 18.8 ± 11.8 min, respectively (P < 0.01). The free-from-endoleak rate at the last follow-up for FSG, BSG, and PSG was 86.9%, 91.9%, and 60.0%, respectively. The last follow-up patency rate for FSG, BSG, and PSG was 85.0%, 91.9%, and 94.1%, respectively. The average reconstruction price of each visceral aortic branch for FSG, BSG, and PSG was 41.40 ± 3.22 thousand RMB, 41.84 ± 3.86 thousand RMB, and 42.35 ± 4.52 thousand RMB, respectively (P = 0.24).Conclusion: To treat the aortic pathologies involving the visceral segment, BSG had a lower endoleak rate and higher branch patency rate when compared with the FSG and PSG techniques. The expense of BSG was comparable to the other two techniques.

16 August 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
JFJiaxuan Feng
Jiaxuan Feng
MRMingjie Rong
Mingjie Rong
YSYu-Dong Sun
Yu-Dong Sun
GZGuanglang Zhu
Guanglang Zhu
GWGuangkuo Wang
Guangkuo Wang
XHXinxin Han
Xinxin Han
Background: Abdominal Aortic Aneurysm (AAA) is a critical global health issue, affecting an estimated up to 8% of men over 65, with a complex etiology involving smoking, age and gender. However, the lack of specific drug treatments underscores the need for a robust in vitro model to advance our comprehension of AAA pathophysiology and serve as an ex vivo surrogate for drug testing.

1 January 2023 in Vascular Investigation and Therapy
Verified
Journal Article
Open access
ZZZhiqing Zhao
Zhiqing Zhao
YSYu-Dong Sun
Yu-Dong Sun
YFYinxing Fan
Yinxing Fan
CWChaochen Wang
Chaochen Wang
XFXinxin Fan
Xinxin Fan
QLQingsheng Lu
Qingsheng Lu
October 2016 to August 2021 from two centers were studied. Carotid artery calcification score was manually segmented on multi-detector row spiral computed tomography angiography scans before CAS. The associations between carotid artery calcification score and the occurrence of CHS during the in-hospital time were assessed. RESULTS: A total of 175 patients were enrolled in the study. The mean age was 72.12 ± 7.51 years. All patients were undergone CAS treatment successfully. There were 46 cases that occurred CHS (26.29%). Univariate logistic regression analyses showed that for every 1 unit (100-score) increase in carotid artery calcification score, the risk of CHS increased by 1937% (odds ratio [OR] = 20.37, 95% confidence interval [CI]: 7.54–55.03, P < 0.01). In addition, the increasing rate was significantly different between the open-cell group (OR = 261.7, P < 0.01) and the closed-cell group (OR = 11.4, P < 0.01). The area under curve of predictiong model of carotid artery calcification score to CHS was 0.84 (95% CI, 0.75–0.93). CONCLUSION: Carotid artery calcification score was an independent risk factor for CHS in patients who underwent CAS. The application of carotid artery calcification score as risk factor in clinical screening of carotid artery stenosis patients may have beneficial effects on the management of CAS....